Effects of cadmium, copper and metallothionein synthesis inhibiting and stimulating compounds on zinc uptake and accumulation in rat hepatoma HTC cells.
Experiments were carried out to investigate the uptake and accumulation of Zn in rat hepatoma HTC cells, as affected by interfering metals (Cd, Cu), metallothionein synthesis inhibiting compounds (Actinomycin D, cycloheximide) and metallothionein synthesis stimulating compounds (dexamethasone, dibu-cAMP). Cell viability was tested under all experimental conditions by the measurement of LDH leakage, K+ uptake and total cell protein. Determinations of Zn were performed by AAS (total Zn) or by gamma-ray spectrometry (65Zn). Metallothionein analysis was carried out by Cd-saturation tests. The results indicate that cellular responses in rat hepatoma HTC cells with respect to the uptake and accumulation of 65Zn are fully comparable with literature data existing for 65Zn accumulation in rat hepatocytes, under all experimental conditions applied. Cu2+ and dibutyryl-cAMP did not significantly affect rates of 65Zn accumulation. Cd2+, Actinomycin D and cycloheximide reduced 65Zn uptake, but dexamethasone additions resulted in increased 65Zn accumulation in the cells. Effects on 65Zn were shown both in cytosolic and in the membranes/organelles cell fractions. HPLC chromatography in control cells suggested that newly accumulated cytosolic 65Zn was predominantly MT-associated. Dexamethasone-induced 65Zn accumulation could not be related to elevated cellular MT levels, nor were the total cytosolic Zn levels significantly affected. Non-specific attenuations in MT levels (Actinomycin D, cycloheximide and dibu-cAMP) yielded linear relations between cytosolic 65Zn and MT levels, without any change in cytosolic Zn (AAS). Combined addition of Cd and dexamethasone yielded elevated MT levels, but severely reduced total cytosolic Zn and 65Zn concentrations. The results further indicate the non-Zn-specific nature of dexamethasone-action and suggest the relatively easy Zn-complexing and Zn-release of MT. The simultaneous determinations of total cytosolic zinc and cytosolic 65Zn levels showed that the application and sole measurement of radiotracers may yield only one-sided views of what is actually present or occurring in the cells.
Steinebach
O M
OM
Department of Radiochemistry, Delft University of Technology, The Netherlands.
Wolterbeek
H T
HT
D000818:Animals; D002104:Cadmium / Q000494:pharmacology*; D002106:Cadmium Radioisotopes; D002462:Cell Membrane / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D003300:Copper / Q000494:pharmacology*; D003301:Copper Radioisotopes; D000242:Cyclic AMP / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003600:Cytosol / Q000737:chemistry; D003609:Dactinomycin / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D008114:Liver Neoplasms, Experimental / Q000378:metabolism*; D008668:Metallothionein / Q000096:biosynthesis*; D011197:Potassium Radioisotopes; D051381:Rats; D014407:Tumor Cells, Cultured; D015032:Zinc / Q000493:pharmacokinetics*; D015037:Zinc Radioisotopes
D002106:Cadmium Radioisotopes; D003301:Copper Radioisotopes; D011197:Potassium Radioisotopes; D015037:Zinc Radioisotopes; D002104:Cadmium; D003609:Dactinomycin; D003300:Copper; D003907:Dexamethasone; D008668:Metallothionein; D003513:Cycloheximide; D000242:Cyclic AMP; D015032:Zinc